芒果视频下载

成立于1998年，知名阿膠品牌，以藥業/酒業為主導，集研發/生產/經營/投資/管理于一體的綜合性集團公司，產品涵蓋了中西藥制劑/生物制藥/原料藥/保健食品等品類

1998年成立的輔仁藥業集團，是一家以藥業、酒業為主導，集研發、生產、經營、投資、管理于一體的綜合性集團公司。集(ji)團(tuan)囊(nang)括河(he)(he)南(nan)(nan)輔(fu)(fu)仁(ren)堂制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、河(he)(he)南(nan)(nan)輔(fu)(fu)仁(ren)懷慶(qing)堂制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、開(kai)(kai)(kai)(kai)封制(zhi)(zhi)藥(yao)(yao)(yao)（集(ji)團(tuan)）有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、開(kai)(kai)(kai)(kai)封豫港制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、開(kai)(kai)(kai)(kai)藥(yao)(yao)(yao)集(ji)團(tuan)（開(kai)(kai)(kai)(kai)魯）制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、河(he)(he)南(nan)(nan)同源制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、輔(fu)(fu)仁(ren)醫(yi)藥(yao)(yao)(yao)科(ke)技開(kai)(kai)(kai)(kai)發有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、輔(fu)(fu)仁(ren)藥(yao)(yao)(yao)業(ye)集(ji)團(tuan)醫(yi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、輔(fu)(fu)仁(ren)藥(yao)(yao)(yao)業(ye)集(ji)團(tuan)熙德隆腫(zhong)瘤藥(yao)(yao)(yao)品有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、北京遠策藥(yao)(yao)(yao)業(ye)有(you)(you)限(xian)(xian)(xian)責任公(gong)(gong)(gong)(gong)司(si)、北京輔(fu)(fu)仁(ren)瑞輝生物醫(yi)藥(yao)(yao)(yao)研(yan)究院、上海(hai)輔(fu)(fu)仁(ren)醫(yi)藥(yao)(yao)(yao)研(yan)發有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、鄭州(zhou)遠策生物制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、河(he)(he)南(nan)(nan)省宋河(he)(he)酒業(ye)股份有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)及上市(shi)公(gong)(gong)(gong)(gong)司(si)輔(fu)(fu)仁(ren)藥(yao)(yao)(yao)業(ye)集(ji)團(tuan)制(zhi)(zhi)藥(yao)(yao)(yao)股份有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)等多家全(quan)資、控股子(zi)公(gong)(gong)(gong)(gong)司(si)。

集團產(chan)(chan)品(pin)涵蓋了(le)中西藥(yao)(yao)制(zhi)劑、生物制(zhi)藥(yao)(yao)、原料藥(yao)(yao)、保健食品(pin)等多個(ge)門類。2006年，隨著河南輔仁(ren)堂制(zhi)藥(yao)(yao)有限公(gong)司成(cheng)功實現上市(shi)，資(zi)本的(de)力量不僅把輔仁(ren)推向一(yi)個(ge)飛速發展時期，其行業(ye)(ye)地位亦逐步提升。2017年12月29日(ri)，輔仁(ren)藥(yao)(yao)業(ye)(ye)重大資(zi)產(chan)(chan)重組成(cheng)功，把集團優(you)質資(zi)產(chan)(chan)——開封制(zhi)藥(yao)(yao)（集團）有限公(gong)司置入輔仁(ren)藥(yao)(yao)業(ye)(ye)，使輔仁(ren)藥(yao)(yao)業(ye)(ye)跨入一(yi)個(ge)新的(de)發展階段。

“品種(zhong)為核心，并(bing)購為主線”的早期(qi)發展戰略讓(rang)輔(fu)(fu)仁藥(yao)業(ye)(ye)集團(tuan)(tuan)的產能和產品線在(zai)很短時間內飛速發展。迄今(jin)，輔(fu)(fu)仁藥(yao)業(ye)(ye)集團(tuan)(tuan)已擁有水(shui)針劑(ji)(ji)、凍(dong)干(gan)粉(fen)針劑(ji)(ji)、口服(fu)固體制劑(ji)(ji)等20多個(ge)(ge)(ge)(ge)劑(ji)(ji)型，1000余個(ge)(ge)(ge)(ge)品種(zhong)；制劑(ji)(ji)綜合產能位居全國制藥(yao)行(xing)業(ye)(ye)前茅(mao)。2017新版(ban)(ban)醫(yi)保(bao)目錄(lu)(lu)輔(fu)(fu)仁藥(yao)業(ye)(ye)集團(tuan)(tuan)共(gong)入選578個(ge)(ge)(ge)(ge)品種(zhong)，較(jiao)2009版(ban)(ban)目錄(lu)(lu)增加品種(zhong)165個(ge)(ge)(ge)(ge)，增幅39.95%，其中甲類入選364個(ge)(ge)(ge)(ge)，增幅42.754%，乙類入選214個(ge)(ge)(ge)(ge)，增幅35.44%。在(zai)國家(jia)衛健委正式發布《國家(jia)基本藥(yao)物目錄(lu)(lu)（2018年(nian)版(ban)(ban)）》中，輔(fu)(fu)仁藥(yao)業(ye)(ye)集團(tuan)(tuan)共(gong)有阿莫(mo)西林克拉維酸(suan)鉀干(gan)混(hun)懸劑(ji)(ji)、奧美拉唑腸溶膠囊、注射用(yong)重組(zu)人(ren)干(gan)擾素α2b等262個(ge)(ge)(ge)(ge)品規(gui)榜上有名，較(jiao)2012版(ban)(ban)目錄(lu)(lu)增加75個(ge)(ge)(ge)(ge)，增幅40.11%，成為全國入選品種(zhong)較(jiao)多的制藥(yao)企業(ye)(ye)之一。

輔(fu)仁藥業集團(tuan)一(yi)直遵循“濟(ji)世藥為(wei)(wei)輔(fu)、惠民(min)(min)志在仁”的(de)(de)(de)企業理念，始(shi)終(zhong)貫(guan)徹“產量(liang)(liang)(liang)讓位于質(zhi)量(liang)(liang)(liang)、成本讓位于質(zhi)量(liang)(liang)(liang)”的(de)(de)(de)質(zhi)量(liang)(liang)(liang)管理方針，本著“和而不同、化繁(fan)為(wei)(wei)簡(jian)、務(wu)實創新(xin)、濟(ji)世惠民(min)(min)”的(de)(de)(de)企業價值觀，把“做一(yi)家實體型、科技型、國(guo)際型企業”作為(wei)(wei)自己(ji)的(de)(de)(de)企業定位，兼容并蓄，尊(zun)重規律，踐(jian)行規則。

在企業(ye)并購的同時，輔仁藥(yao)業(ye)集團投(tou)入巨資加強企業(ye)創(chuang)新(xin)(xin)(xin)平臺(tai)(tai)建設，戰略性布局鄭州技術研(yan)發(fa)(fa)和(he)國際(ji)化(hua)合(he)作及產業(ye)化(hua)服務平臺(tai)(tai)、北京創(chuang)新(xin)(xin)(xin)研(yan)發(fa)(fa)平臺(tai)(tai)、上海醫(yi)藥(yao)研(yan)發(fa)(fa)創(chuang)新(xin)(xin)(xin)國際(ji)合(he)作平臺(tai)(tai)、美國新(xin)(xin)(xin)澤西、費城研(yan)發(fa)(fa)平臺(tai)(tai)四大(da)研(yan)發(fa)(fa)創(chuang)新(xin)(xin)(xin)平臺(tai)(tai)，以及中醫(yi)藥(yao)大(da)數據及人工智能(neng)中醫(yi)研(yan)發(fa)(fa)平臺(tai)(tai)，更將在小分(fen)子(zi)化(hua)學藥(yao)、大(da)分(fen)子(zi)生物藥(yao)研(yan)發(fa)(fa)和(he)中醫(yi)藥(yao)傳承創(chuang)新(xin)(xin)(xin)方向同時發(fa)(fa)力(li)，開辟以研(yan)發(fa)(fa)驅動創(chuang)新(xin)(xin)(xin)的發(fa)(fa)展新(xin)(xin)(xin)路徑。

目前，輔(fu)(fu)仁藥(yao)(yao)業集團支(zhi)持(chi)創(chuang)新研(yan)發(fa)(fa)面積達(da)11.3萬平(ping)方米，研(yan)發(fa)(fa)創(chuang)新隊伍近1500人(ren)。同時(shi)，秉承“中(zhong)國(guo)市(shi)場、輔(fu)(fu)仁平(ping)臺(tai)、全球資源(yuan)”的(de)發(fa)(fa)展策略(lve)，輔(fu)(fu)仁藥(yao)(yao)業集團實現(xian)了從“百(bai)姓藥(yao)(yao)、輔(fu)(fu)仁造(zao)”到“創(chuang)新藥(yao)(yao)、輔(fu)(fu)仁造(zao)”的(de)可持(chi)續發(fa)(fa)展跨越，為客戶及(ji)整個(ge)社(she)會創(chuang)造(zao)價(jia)值，健康中(zhong)國(guo)，服務世界(jie)。